Unifi Inc. (NYSE:UFI) shares decreased -0.66% in last trading session and ended the day at $28.46. UFI Gross Margin is 13.20% and its has a return on assets of 8.90%. Unifi Inc. (NYSE:UFI) quarterly performance is -12.16%.
Unifi Inc. (NYSE:UFI) said that, it will host a conference call and web cast at 8:30 a.m., Eastern Time, on Thursday, October 22, 2015, to discuss its preliminary financial results for the first fiscal quarter ended September 27, 2015.
TAL International Group, Inc. (NYSE:TAL) ended the last trading day at $16.91. Company weekly volatility is calculated as 6.58% and price to cash ratio as 7.79. TAL International Group, Inc. (NYSE:TAL) showed a weekly performance of -6.42%.
TAL International Group, Inc. (NYSE:TAL) announced that it will report its financial results for the third quarter ended September 30, 2015 after the market closes on Wednesday, October 28, 2015. The Company’s management will host a conference call on Thursday, October 29, 2015 at 9:00 a.m. ET to review the third quarter financial results.
On 16 October, Luxoft Holding, Inc. (NYSE:LXFT) shares decreased -0.23% and was closed at $65.40. Luxoft Holding, Inc. (NYSE:LXFT) year to date (YTD) performance is 69.83%.
Luxoft Holding, Inc. (NYSE:LXFT) said that, it will announce its financial results for the second quarter and the six months ended September 30, 2015 on Tuesday, November 10, 2015 after market close.
Southwest Airlines Co. (NYSE:LUV) shares fell -1.65% in last trading session and ended the day at $40.56. LUV Gross Margin is 69.20% and its has a return on assets of 7.60%. Southwest Airlines Co. (NYSE:LUV) quarterly performance is 18.44%.
Southwest Airlines Co. (NYSE:LUV) has finally launched its international terminal at Houston’s Hobby airport. Following the launch, the carrier has started operating international flights from the new five-gate terminal. The move is consistent with the company’s plans to expand international operations and improve customer convenience.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) caters to the Healthcare space. It has a net profit margin of 13.60% and weekly performance is 2.12%. On the last day of trading company shares ended up at $514.59. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) distance from 50-day simple moving average (SMA50) is -1.94%.
Vetr downgraded shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) from a strong-buy rating to a buy rating in a research report published on Monday, MarketBeatreports. Vetr currently has $579.76 price objective on the biopharmaceutical company’s stock.
Leave a Reply